Search Results 1391-1400 of 18372 for Lupus

1. Medical Research & Education - Mayo Clinic News Network

   In a new study, Mayo Clinic researchers and collaborators have described — for the first time — the prevalence of autoimmune diseases in the U.S.[...] ...

2. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

   Known autoimmune disease, including but not limited to, celiac disease, or preexisting symptoms of systemic lupus erythematosus, scleroderma or other ...

3. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

   Note: Overlap with features of SSc, systemic lupus erythematosus, Sjogren's syndrome, or rheumatoid arthritis is allowed if the dominant clinical disease is DM.

4. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

   Presence of uncontrolled systemic lupus erythematosus (as per clinical judgment) 7. Substance or alcohol abuse (current alcohol use > 3 alcoholic beverage ...

5. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

6. Gout - Doctors and departments - Mayo Clinic

   D. Internist; Rheumatologist. Rochester, MN. Areas of focus: Scleroderma, Lupus, Sjogren's syndrome, Gout, Inflammatory arthritis, Inflammatory myopathy. There ...

7. Pembrolizumab and berahyaluronidase alfa-pmph (subcutaneous route) - Side effects & uses - Mayo Clinic

   Immune system problems (eg, Crohn's disease, ulcerative colitis, lupus) or; Nephritis (inflammation of the kidneys) or; Nervous system problems (eg, Guillain ...

8. Side effects - or lack of side effects - after being vaccinated for COVID-19 - Mayo Clinic News Network

   Starting from the beginning may lead to better outcomes for lupus. Related Articles. Mayo Clinic Minute: Treating severe headaches caused by nerve compression ...

9. Tremelimumab-actl (intravenous route) - Side effects & uses - Mayo Clinic

   Adrenal gland problems or; Diabetes or; Immune system problems (eg, Crohn's disease, ulcerative colitis, lupus) or; Kidney problems or; Nervous system problems ...

10. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

    History or current autoimmune disease requiring systemic treatment (eg, Crohn disease, ulcerative colitis, rheumatoid arthritis, systemic lupus). 33 ...